Registered business in FR. Official registry identity, filed financial evidence and a public indicative value curve on one indexed company profile.
Historical indicative ranges based on public filings. This is not an asking price or confirmation that the company is for sale.
Based on filed company accountsThe historical value curve is public. Create a free account for the future five-year growth outlook, the insights behind it, and concrete action points that can increase this company’s value.
Free account · private workspace
Each step adds evidence that narrows the range. Public filings are a starting point. Connected accounts, owner context and method review make the valuation more useful for real decisions.
Own this company? Claim and manage the profileYou have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The valuation for ISISPHARMA FRANCE combines official public company figures with Upswitch sector calibration. The owner can sharpen it with their own figures and context into a full, defensible valuation curve.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Operating as a business in NACE sector 46.45, ISISPHARMA FRANCE is registered in France. The company was founded in 2007, incorporated as a 5710.
ISISPHARMA FRANCE is listed in French National Business Register (RNE/INPI) under registry number 499855013. The public employee band is 21, a useful triage field for banks, credit analysts, and M&A acquirers. This profile consolidates official annual accounts into one indexable company dossier.
Within the French NACE 46.45 cluster, public-record data is filed annually via the national company registry.
Across the 2017-2024 window revenue has more than doubled, moving from €10,796,977 to €24,557,564.
A public indicative value curve is available for ISISPHARMA FRANCE, based on filed company accounts. A free account unlocks the five-year outlook and concrete actions to increase value.
The most recent annual filing covers 2024 (period end 2024-09-30).
This page is refreshed whenever new regulator-filed data for ISISPHARMA FRANCE becomes available, consolidated into a single audit-grade view.
Public regulator-filed figures across 8 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202430 Sept 2024 | €24,557,564 | - | €16,981,040 | €3,736,503 | - |
| 202330 Sept 2023 | €22,142,091 | - | €13,917,951 | €2,663,398 | - |
| 202230 Sept 2022 | €17,757,054 | - | €12,334,631 | €1,516,325 | - |
| 202130 Sept 2021 | €14,370,529 | - | €11,513,829 |
ISISPHARMA FRANCE was founded in 2007 and is registered with French National Business Register (RNE/INPI), incorporated as a 5710.
ISISPHARMA FRANCE is registered under NACE 46.45: NACE 46.45. That places the business within the French cluster for this activity.
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for ISISPHARMA FRANCE may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
| €653,313 |
| - |
| 202030 Sept 2020 | €10,142,920 | - | €7,769,511 | €914,631 | - |
| 201930 Sept 2019 | €13,439,885 | - | €8,554,331 | €129,370 | - |
| 201830 Sept 2018 | €9,859,181 | - | €7,583,207 | €701,611 | - |
| 201730 Sept 2017 | €10,796,977 | - | €7,934,929 | €642,493 | - |
The most recently filed annual accounts cover fiscal year 2024 (period end 2024-09-30), publicly available via French National Business Register (RNE/INPI).
